TrialScientific reports2026

CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteers.

Yves Levy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.